James Sapirstein - 11 Jul 2025 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role
Director
Signature
/s/ Stephen C. Glover as Attorney-in-Fact for James Sapirstein pursuant to Power of Attorney
Issuer symbol
ZVSA
Transactions as of
11 Jul 2025
Transactions value $
$0
Form type
4
Filing time
15 Jul 2025, 16:22:47 UTC
Previous filing
30 Sep 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SAPIRSTEIN JAMES Director C/O ZYVERSA THERAPEUTICS, INC., 2200 N. COMMERCE PARKWAY, SUITE 208, WESTON /s/ Stephen C. Glover as Attorney-in-Fact for James Sapirstein pursuant to Power of Attorney 14 Jul 2025 0001559509

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVSA Stock Options Award $0 +11.1K $0.00 11.1K 11 Jul 2025 Common Stock 11.1K $0.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date.